Maynard Um
-
-
-
-
-
-
-
Guggenheim Downgrades AtaiBeckley Inc (ATAI) to Neutral
-
-
-
-
-
-
-
AtaiBeckley Inc (ATAI) PT Raised to $17 at Canaccord
-
-
-
-
-
-
-
White House Prepares Order On Ibogaine Psychedelic - CBS
-
-
-
-
-
-
-
AtaiBeckley outlines 2026 clinical trial timeline ahead of JP Morgan conference
-
-
-
-
-
-
-
Needham Starts atai Life Sciences N.V (ATAI) at Buy
-
-
-
-
-
-
-
Aegis Capital Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
-
443,976 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

